NCT05932667 2023-12-21
DEMETER
Institut Curie
Phase 2 Terminated
Clinical Trials
5 trialsNCT04638712 2023-02-09
PROTECT-03
Institut de cancérologie Strasbourg Europe
Phase NA Completed
NCT05670054 2023-01-04
Cyclin Dependant Kinase 4/6 (CDK4/6) Inhibitors as a Second Line Treatment in Metastatic Breast Cancer Patients
Mansoura University
Phase 3 Unknown
NCT03636776 2022-12-29
EPOCA
Institut Cancerologie de l'Ouest
Phase NA Terminated
NCT00712621 2009-11-24
Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination
American Scitech International
Phase 2 Withdrawn